Evidence mapPaperPMID 25538311Full record

ReviewDiabetes care2015

BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening.

William C Hsu, Maria Rosario G Araneta, Alka M Kanaya, Jane L Chiang, Wilfred Fujimoto

Registry-linked trialAbstract readReview
In one paragraph

Review in Diabetes care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03038620 (Impact of Liraglutide 3.0 on Body Fat Distribution, Visceral Adiposity, and Cardiometabolic Risk Markers In Overweight and Obese Adults at High Risk for Cardiovascular Disease), which is not on this map. Cited by 268 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
268citing papers in PubMed, 2 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03038620 phase4completedstarted 2017, after this paper: background citation

Impact of Liraglutide 3.0 on Body Fat Distribution, Visceral Adiposity, and Cardiometabolic Risk Markers In Overweight and Obese Adults at High Risk for Cardiovascular Disease

Ran2017Enrolled235Registered outcomes37Posted comparisons0ConditionsCardiovascular Diseases, Fat Disorder, Obesity, VisceralArmsliraglutide, Placebo
Open the trial in the graph
3 · Its place in the literature

Who cites it

268 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

208 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

William C HsuAsian American Diabetes Initiative, Joslin Diabetes Center, Harvard Medical School, Boston, MA william.hsu@joslin.harvard.edu.
Maria Rosario G AranetaDepartment of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA.
Alka M KanayaDivision of General Internal Medicine, University of California, San Francisco, San Francisco, CA.
Jane L ChiangAmerican Diabetes Association, Alexandria, VA.
Wilfred FujimotoDepartment of Medicine, University of Washington, Seattle, WA.

Funding

PILOT &FEASIBILTY 2P30DK063720 · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · 2003 to 2005
$3.6M
NHLBI NIH HHS K24 HL112827NHLBI NIH HHS R01 HL093009NIDDK NIH HHS P30 DK063720
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsianBody Mass IndexAdultAgedDiabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedObesityOverweightPrevalenceReference ValuesRisk FactorsWaist Circumference

Identifiers

PMID25538311
PMCPMC4392932

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.